ArticleRheumatology and therapy2023

Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.

Bernard G Combe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.